Revance Therapeutics Inc (RVNC)
5.80
-0.10
(-1.69%)
USD |
NASDAQ |
Nov 01, 16:00
5.795
0.00 (0.00%)
After-Hours: 20:00
Revance Therapeutics Debt to Equity Ratio: -3.319 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | -3.319 |
| March 31, 2024 | -4.356 |
| December 31, 2023 | -2.830 |
| September 30, 2023 | -4.033 |
| June 30, 2023 | 14.20 |
| March 31, 2023 | -14.24 |
| December 31, 2022 | 30.11 |
| September 30, 2022 | 2.600 |
| June 30, 2022 | -143.82 |
| March 31, 2022 | 14.80 |
| December 31, 2021 | 4.099 |
| September 30, 2021 | 2.333 |
| June 30, 2021 | 1.504 |
| March 31, 2021 | 1.145 |
| December 31, 2020 | 0.4823 |
| September 30, 2020 | 0.4757 |
| June 30, 2020 | 0.6816 |
| March 31, 2020 | 0.5555 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.0149 |
| September 30, 2014 | 0.0461 |
| June 30, 2014 | 0.054 |
| March 31, 2014 | 0.1754 |
| December 31, 2013 | -0.1618 |
| September 30, 2013 | -0.5823 |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | -0.4868 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-143.82
Minimum
Jun 2022
30.11
Maximum
Dec 2022
-5.243
Average
0.5555
Median
Mar 2020
Debt to Equity Ratio Benchmarks
| Recursion Pharmaceuticals Inc | 0.0531 |
| Moderna Inc | 0.00 |
| Pacira BioSciences Inc | 0.6702 |
| PetIQ Inc | 1.717 |
| Anebulo Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 494.80M |
| Total Liabilities (Quarterly) | 624.54M |
| Shareholders Equity (Quarterly) | -129.74M |
| Current Ratio | 3.740 |
| Net Debt Paydown Yield | -3.77% |